BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 194338)

  • 1. [Refractory anemia with partial myeloblastosis in multiple myeloma treated with melphalan].
    Morlock G; Bataille R; Sany J; Serre H
    Sem Hop; 1977 Apr 9-16; 53(14-15):853-6. PubMed ID: 194338
    [No Abstract]   [Full Text] [Related]  

  • 2. Breast cancer and acute leukemia in a patient with multiple myeloma treated with melphalan.
    Meytes D; Katz DR
    Isr J Med Sci; 1973 Aug; 9(8):1044-7. PubMed ID: 4753846
    [No Abstract]   [Full Text] [Related]  

  • 3. [Silent onset of multiple myeloma. How to diagnosis and when to treat?].
    Bartl R
    Internist (Berl); 1986 Mar; 27(3):192-200. PubMed ID: 3086250
    [No Abstract]   [Full Text] [Related]  

  • 4. Multiple myeloma and acute leukemia associated with alkylating agents.
    Kyle RA; Pierre RV; Bayrd ED
    Arch Intern Med; 1975 Jan; 135(1):185-92. PubMed ID: 1053891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Erythroleukemia in multiple myeloma. A case report].
    Streuli R; Voellmy W
    Schweiz Med Wochenschr; 1987 Feb; 117(8):286-91. PubMed ID: 3470922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Myeloma, melphalan and acute myelo-monocytic leukemia. Apropos of a case].
    Cywiner-Golenzer C; Adotti F; Marsan C; Quillard A; Henon P; Grimaldi A; Dryll A
    Sem Hop; 1974 Jan; 50(3):207-11. PubMed ID: 4367926
    [No Abstract]   [Full Text] [Related]  

  • 7. [Sideroblastic anemia in a multiple myeloma treated by melphalan (author's transl)].
    Phelip X; Grosclaude S; Rouge P; Mouries D; Blanc D
    Sem Hop; 1979 Oct 18-25; 55(35-36):1633-5. PubMed ID: 231836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic factors and the effect of alkylating agents on survival in multiple myeloma. A review of 80 patients.
    Matzner Y; Benbassat J; Polliack A
    Isr J Med Sci; 1977 Aug; 13(8):797-807. PubMed ID: 408296
    [No Abstract]   [Full Text] [Related]  

  • 9. [A myeloma (IgG-kappa) terminating in acute myelogenous leukemia].
    Fujii H; Yashige H; Taniwaki M; Urata Y; Kuzuyama Y; Kitagawa Y; Horishi M; Suyama Y; Miyoshi M
    Gan No Rinsho; 1990 Apr; 36(5):645-50. PubMed ID: 2109137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Multiple myeloma and acute leukemia. Simultaneous evolution of plasmacyte and myelomonocytic clones].
    Renoux M; Bernard JF; Bezeau A; Amar M; Boivin P
    Sem Hop; 1978 Sep 18-25; 54(25-28):809-13. PubMed ID: 214859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Refractory anemia with hypercellular bone marrow and preleukemia (author's transl)].
    Fischer M; Mitrou PS
    Med Klin; 1976 Nov; 71(48):2127-35. PubMed ID: 1004362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IgE-type multiple myeloma with the late development of IgA2 kappa and plasma cell leukaemia.
    Chiu W; Pullon H; Woon ST; Oei P; The R; Ameratunga R
    Pathology; 2010 Jan; 42(1):82-4. PubMed ID: 20025486
    [No Abstract]   [Full Text] [Related]  

  • 13. [Dysmyelopoietic syndrome 7 years after melphalan treatment of multiple myeloma. Clinical case].
    Scolozzi R; Boccafogli A
    Minerva Med; 1983 Jul; 74(28-29):1783-5. PubMed ID: 6866310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Dhnmics of histological changes in the bone marrow in a patient with multiple myeloma during the process of treatment with sarcolysin].
    Voronin VM; Rybakova ME
    Probl Gematol Pereliv Krovi; 1969 Feb; 14(2):53-6. PubMed ID: 5351088
    [No Abstract]   [Full Text] [Related]  

  • 15. The plasma cells of the bone marrow in myelomatosis treated with Alkeran (melphalan).
    Axelsson U
    Scand J Haematol; 1966; 3(2):123-35. PubMed ID: 5946776
    [No Abstract]   [Full Text] [Related]  

  • 16. Multiple myeloma and acute myelomonocytic leukemia.
    Kyle RA; Pierre RV; Bayrd ED
    N Engl J Med; 1970 Nov; 283(21):1121-5. PubMed ID: 5273282
    [No Abstract]   [Full Text] [Related]  

  • 17. Thrombocythaemia and multiple myeloma. A report on two cases.
    Selroos O; van Assendelft A
    Acta Med Scand; 1977; 201(3):243-7. PubMed ID: 557871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Plasmocytic pleural effusion disclosing multiple myeloma].
    Elloumi M; Frikha M; Masmoudi H; Mseddi S; Ben Ayed M; Bouaziz M; Makni F; Souissi T
    Rev Mal Respir; 2000 Apr; 17(2):495-7. PubMed ID: 10859769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Multiple myeloma preceding myelodysplastic syndrome with eosinophilia and der (1;7)].
    Matano S; Kobayashi K; Nakamura S; Yoshida T
    Rinsho Ketsueki; 1994 Nov; 35(11):1310-4. PubMed ID: 7823398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coexistence of myelodysplastic syndrome and multiple myeloma.
    Tsiara S; Economou G; Panteli A; Isaakidis P; Kapsali E; Bourantas KL
    J Exp Clin Cancer Res; 1999 Dec; 18(4):565-6. PubMed ID: 10746986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.